v3.26.3
Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net Income (Loss) $ (13,044,799) $ (14,065,948)
Reconciliation of net loss to net cash used in operating activities    
Depreciation and amortization expense 17,650 24,902
Operating lease expense 93,643 83,707
Warrants issued for services 497,076
Stock-based compensation 259,354 484,947
Stock issued for services 1,000,000
Bad debt expense 1,632 31,295
Expenses paid on behalf of the Company 26,232
Changes in operating assets and liabilities:    
Accounts receivable (1,667) (161,237)
Accounts receivable - related party 47,903 128,198
Prepaid assets – related party (80,000)
Prepaid assets (11,422)
Other current assets (32,791) (584)
Operating lease liability (91,220) (75,061)
Accounts payable and accrued expenses 1,443,938 611,991
Accounts payable and accrued expenses - related party 427,447 55,669
Deferred revenue (85,773) 52,754
Net cash used in operating activities (10,029,873) (12,332,291)
Cash flows from investing activities:    
Purchase of property and equipment (23,199) (26,882)
Net cash used in investing activities (23,199) (26,882)
Cash flows from financing activities:    
Proceeds from issuance of Class A common stock 2,700,000 4,400,000
Proceeds from issuance of Class A common stock - related party 1,500,000
Proceeds from Class A common stock subscriptions 8,329,808
Transaction fees payable from Class A common stock subscriptions (311,450)  
Proceeds from warrant exercise 332,500
Repayments on notes payable (70,705)
Payments on finance lease (546)
Proceeds from convertible note payable - related party 7,443,503 2,952,000
Repayments on convertible note payable - related party (1,161,445)
Net cash provided by financing activities 18,423,656 7,690,009
Net change in cash 8,370,584 (4,669,164)
Cash, beginning of period 549,249 5,218,413
Cash, end of period 8,919,833 549,249
Non-cash investing and financing activities:    
Shares issued upon conversion of related party convertible notes 7,840,106 778
D&O Insurance Policy Financing 143,949
Deemed dividend for warrant reissuance 11,411,498
Reclassification of Series A temporary equity to stockholder’s equity $ 120,000,000